Bradley P. Knight, MD, FACC, FHRS, Editor-in-Chief
Bradley P. Knight, MD, FACC, FHRS, Ed...
The U.S. Food and Drug Administration (FDA) approved Boston Scientific’s WATCHMAN™ Left Atrial Appendage Closure (LAAC) device on March 13, 2015 for stroke prevention in patients with atrial fibrillation (AF). Indication and contraindication...
The U.S. Food and Drug Administration (FDA) approved Boston Scientific’s WATCHMAN™ Left Atrial Appendage Closure (LAAC) device on March 13, 2015 for stroke prevention in patients with atrial fibrillation (AF). Indication and contraindication...
The U.S. Food and Drug...